Pandolfi, Franco
 Distribuzione geografica
Continente #
NA - Nord America 6.420
AS - Asia 3.785
EU - Europa 3.354
SA - Sud America 779
Continente sconosciuto - Info sul continente non disponibili 94
AF - Africa 81
OC - Oceania 20
Totale 14.533
Nazione #
US - Stati Uniti d'America 6.198
SG - Singapore 1.821
CN - Cina 931
DE - Germania 888
BR - Brasile 639
SE - Svezia 533
UA - Ucraina 518
FR - Francia 325
IT - Italia 319
VN - Vietnam 251
IE - Irlanda 223
GB - Regno Unito 143
ID - Indonesia 140
FI - Finlandia 136
IN - India 125
RU - Federazione Russa 99
CA - Canada 96
BD - Bangladesh 87
JP - Giappone 86
HK - Hong Kong 57
TR - Turchia 52
AR - Argentina 49
MX - Messico 43
IQ - Iraq 39
PL - Polonia 33
NL - Olanda 26
PK - Pakistan 26
BE - Belgio 25
SA - Arabia Saudita 25
ZA - Sudafrica 25
EC - Ecuador 23
CO - Colombia 20
AU - Australia 18
JM - Giamaica 18
PH - Filippine 18
ES - Italia 17
VE - Venezuela 14
KR - Corea 13
CL - Cile 11
MA - Marocco 11
MY - Malesia 11
UZ - Uzbekistan 11
IR - Iran 10
CH - Svizzera 9
HN - Honduras 9
IL - Israele 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CR - Costa Rica 8
PR - Porto Rico 8
PY - Paraguay 8
TN - Tunisia 8
JO - Giordania 7
KE - Kenya 7
UY - Uruguay 7
DZ - Algeria 6
KZ - Kazakistan 6
LB - Libano 6
NP - Nepal 6
CZ - Repubblica Ceca 5
GT - Guatemala 5
PA - Panama 5
PE - Perù 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AL - Albania 4
AT - Austria 4
DK - Danimarca 4
EE - Estonia 4
EG - Egitto 4
LT - Lituania 4
MK - Macedonia 4
PT - Portogallo 4
RO - Romania 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
CI - Costa d'Avorio 3
ET - Etiopia 3
GP - Guadalupe 3
HU - Ungheria 3
KG - Kirghizistan 3
MM - Myanmar 3
MN - Mongolia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
TH - Thailandia 3
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IS - Islanda 2
KW - Kuwait 2
NO - Norvegia 2
Totale 14.410
Città #
Ashburn 893
Singapore 883
San Jose 545
Chandler 515
Jacksonville 267
Dublin 215
San Mateo 214
Beijing 198
Wilmington 125
Jakarta 124
Nanjing 111
Ann Arbor 108
Lauterbourg 105
Boston 89
Hefei 89
Lawrence 89
Los Angeles 84
Hanoi 75
Cattolica 73
Council Bluffs 73
New York 71
Dearborn 70
Houston 69
Ho Chi Minh City 68
Tokyo 65
Moscow 63
Woodbridge 52
Dallas 50
Fairfield 48
Boardman 47
Redwood City 47
Hong Kong 46
Frankfurt am Main 45
Seattle 45
São Paulo 45
Chicago 43
Santa Clara 43
Buffalo 40
Detroit 40
Milan 40
Marseille 34
Mountain View 34
Helsinki 33
Kent 33
Nürnberg 33
Hangzhou 32
Lancaster 32
Nanchang 32
North Bergen 32
Shenyang 32
Munich 31
Rio de Janeiro 31
University Park 31
Hebei 29
Shanghai 29
Atlanta 28
Brooklyn 28
Rome 28
Princeton 23
Izmir 22
Brussels 20
Cambridge 20
Bremen 19
Guangzhou 19
Norwalk 19
Washington 19
Changsha 18
Jiaxing 18
Montreal 18
Toronto 18
Baghdad 17
London 16
Phoenix 16
The Dalles 16
Da Nang 15
Paris 15
Philadelphia 15
Tianjin 15
Belo Horizonte 14
Jinan 14
Kraków 14
Memphis 14
Zhengzhou 14
Kingston 13
Pune 13
Brasília 12
Fremont 12
Johannesburg 12
Tukwila 12
Ankara 11
Charlotte 11
Dhaka 11
Guayaquil 11
Nuremberg 11
Stockholm 11
Warsaw 11
Denver 10
Düsseldorf 10
Las Vegas 10
Orem 10
Totale 7.093
Nome #
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 341
Strategies to overcome obstacles to successful immunotherapy of melanoma 259
Biased T cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (Di George syndrome/velocardiofacial syndrome) 251
Can vitamin a mediate immunity and inflammation? 205
Impact of mast cells in rejection of allografts 198
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 189
Interleukin-6 in Rheumatoid Arthritis 181
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair 176
Reflux symptoms in wind instrument players. 175
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 175
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 175
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin 175
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology 169
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 168
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease 162
IL-32: a newly-discovered proinflammatory cytokine 159
The immune response to tumors as a tool toward immunotherapy 159
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 158
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. 157
Role of vitamins D, E and C in immunity and inflammation. 157
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 157
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. 153
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 149
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 149
New insights on the role of T cells in the pathogenesis of celiac disease. 147
New insights on the role of T-cels in the pathogenesis of Celiac Disease 146
Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease 145
Third-line rescue therapy for Helicobacter pylori infection 143
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system 143
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 141
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 141
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop 140
Allele*1 of HS1,2 enhancer associates with selective IgA deficiency and IgM concentration 139
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration 138
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. 138
Cellular mediators of inflammation: tregs and t(h)17 cells in gastrointestinal diseases. 136
Interrelationship between IL-3 and mast cells 134
T-cell receptor repertoire and function in patients with Di George Syndrome and velocardiofacial syndrome. 133
TLR2: a crossroads between infections and autoimmunity? 130
New insight into systemic mastocytosis mediated by cytokines IL-1 beta and IL-33: Potential inhibitory effect of IL-37 128
Third-line rescue therapy for Helicobacter pylori infection. 127
Impact of IL-18 on inflammation 127
Integrins: Integrating the Biology and Therapy of Cell-cell Interactions 127
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 127
Impact of Fungi on Immune Responses 126
Activity of caffeic acid derivatives against Candida albicans biofilm 125
TLR2: a crossroads between infections and autoimmunity? 124
Current Challenges in Immunology 124
Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37 123
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 122
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART 122
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 122
Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand 122
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. 119
Luteolin inhibits mast cell-mediated allergic inflammation. 118
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. 117
VEGF, substance P and stress, new aspects: a revisited study. 117
Mast cell involvement in rheumatoid arthritis. 117
High prevalence of hyperplastic colonic polyps in acromegalic subjects 116
Impairment of recent thymic emigrants in HCV infection. 116
The impact of biological agents interfering with receptor/ligand binding in the immune system. 115
Strategies to overcome obstacles to successful immunotherapy of melanoma. 115
Role of mast cells in innate and adaptive immunity. 115
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group 111
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and IL-2 in vitro 110
Abnormal synthesis of IgA in coeliac disease and related disorderd 108
BALKAN ENDEMIC NEPHROPATHY RISK ASSOCIATES TO THE HS1.2 IG ENHANCER POLYMORPHISM 108
The number of HIV-DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2. 107
Apoptosis in the homeostasis of the immune system and in human immune mediated diseases 107
Epatite da farmaci 106
Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation 106
Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 103
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). 101
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. 101
IL-31 a Th2 cytokine involved in immunity and inflammation. 100
Vascular endothelial growth factor (VEGF), mast cells and inflammation. 100
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids 100
A novel autocrine pathway of tumor escape immune recognition; melanoma cell produce a soluble protein that diminuishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down modulation of its promoter. 99
Active thymopoiesis in idiopathic chronic pancreatitis 99
Involvment of central immunity in uncomplicated diverticular disease. 99
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells 99
Nerve growth factor interactions with mast cells 98
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease 98
Induction of "antigen silencing" in melanomas by oncostatin M: downmodulation of melanocyte antigen expression. 97
Impact of mast cells on the skin. 97
Vitamins and mast cells. 96
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 95
Oligoclonality of Vdelta1 and Vdelta2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with gram-negative bacteria 95
Decreased CD 95 expression on naive T cells from HIV infected persons undergoing highly active antiretroviral therapy (HAART) and the influence of IL-2 low dose administration 95
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 95
Impact of IL -9 and IL-33 in mast cells 94
Involvement of central immunity in uncomplicated diverticular disease 93
Interrelationship between IL-3 and mast cells 91
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes 90
IL-36 receptor antagonist with special emphasis on IL-38. 90
Psychological stress and vitamins 90
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation 89
Allergic inflammation: role of cytokines with special emphasis on IL-4 87
Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficiencies 87
Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia. 86
Totale 13.029
Categoria #
all - tutte 61.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022610 0 0 0 0 47 34 11 127 39 44 118 190
2022/20231.587 233 182 156 207 156 203 55 94 166 44 60 31
2023/2024918 30 284 25 129 27 107 23 44 21 39 93 96
2024/20251.646 46 72 146 38 107 51 18 112 298 114 325 319
2025/20264.333 702 132 301 411 697 206 732 215 273 349 176 139
2026/20271.838 180 672 280 654 52 0 0 0 0 0 0 0
Totale 14.533